Browse Mouse Gene Sets

Gene set name:

 
  (Enter full or partial name)

By first letter:

 

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

By collection:

[about the MSigDB Mouse collections]

  • MH (orthology-mapped hallmark gene sets, 50 gene sets)
  • M1 (positional gene sets, 341 gene sets)
  • M2 (curated gene sets, 2619 gene sets)
    • CGP (chemical and genetic pertubations, 932 gene sets)
    • CP (canonical pathways, 1687 gene sets)
  • M3 (regulatory gene sets, 2042 gene sets)
    • GTRD (GTRD transcription factor targets, 273 gene sets)
    • MIRDB (miRDB microRNA targets, 1769 gene sets)
  • M5 (ontology gene sets, 10652 gene sets)
    • GO (Gene Ontology, 10560 gene sets)
      • GO:BP (GO biological process, 7775 gene sets)
      • GO:CC (GO cellular component, 1039 gene sets)
      • GO:MF (GO molecular function, 1746 gene sets)
    • MPT (Mouse Phenotype Ontology MP Tumor, 92 gene sets)
  • M8 (cell type signature gene sets, 214 gene sets)

Click on a gene set name to view its gene set page.

MP_ABNORMAL_TUMOR_VASCULARIZATION
MP_DECREASED_CIRCULATING_TUMOR_NECR
OSIS_FACTOR_LEVEL

MP_DECREASED_INCIDENCE_OF_INDUCED_T
UMORS

MP_DECREASED_INCIDENCE_OF_TUMORS_BY
_CHEMICAL_INDUCTION

MP_DECREASED_LIVER_TUMOR_INCIDENCE
MP_DECREASED_LUNG_TUMOR_INCIDENCE
MP_DECREASED_METASTATIC_POTENTIAL
MP_DECREASED_TUMOR_GROWTH_SIZE
MP_DECREASED_TUMOR_INCIDENCE
MP_DECREASED_TUMOR_LATENCY
MP_DECREASED_TUMOR_NECROSIS_FACTOR_
SECRETION

MP_EMBRYO_TUMOR
MP_INCREASED_ACUTE_LYMPHOBLASTIC_LE
UKEMIA_INCIDENCE

MP_INCREASED_ADENOCARCINOMA_INCIDEN
CE

MP_INCREASED_ADENOMA_INCIDENCE
MP_INCREASED_ADRENAL_GLAND_TUMOR_IN
CIDENCE

MP_INCREASED_B_CELL_DERIVED_LYMPHOM
A_INCIDENCE

MP_INCREASED_BASAL_CELL_CARCINOMA_I
NCIDENCE

MP_INCREASED_BRAIN_TUMOR_INCIDENCE
MP_INCREASED_CARCINOMA_INCIDENCE
MP_INCREASED_CHRONIC_MYELOCYTIC_LEU
KEMIA_INCIDENCE

MP_INCREASED_CIRCULATING_TUMOR_NECR
OSIS_FACTOR_LEVEL

MP_INCREASED_COLON_ADENOCARCINOMA_I
NCIDENCE

MP_INCREASED_COLON_ADENOMA_INCIDENC
E

MP_INCREASED_ENDOMETRIAL_CARCINOMA_
INCIDENCE

MP_INCREASED_FIBROSARCOMA_INCIDENCE
MP_INCREASED_GASTROINTESTINAL_TUMOR
_INCIDENCE

MP_INCREASED_GRANULOSA_CELL_TUMOR_I
NCIDENCE

MP_INCREASED_HAMARTOMA_INCIDENCE
MP_INCREASED_HEMANGIOMA_INCIDENCE
MP_INCREASED_HEMANGIOSARCOMA_INCIDE
NCE

MP_INCREASED_HEMOLYMPHOID_SYSTEM_TU
MOR_INCIDENCE

MP_INCREASED_HEPATIC_HEMANGIOMA_INC
IDENCE

MP_INCREASED_HEPATOCELLULAR_CARCINO
MA_INCIDENCE

MP_INCREASED_HEPATOMA_INCIDENCE
MP_INCREASED_HISTIOCYTIC_SARCOMA_IN
CIDENCE

MP_INCREASED_INCIDENCE_OF_INDUCED_T
UMORS

MP_INCREASED_INCIDENCE_OF_TUMORS_BY
_CHEMICAL_INDUCTION

MP_INCREASED_INCIDENCE_OF_TUMORS_BY
_IONIZING_RADIATION_INDUCTION

MP_INCREASED_INCIDENCE_OF_TUMORS_BY
_UV_INDUCTION

MP_INCREASED_INTESTINAL_ADENOCARCIN
OMA_INCIDENCE

MP_INCREASED_INTESTINAL_ADENOMA_INC
IDENCE

MP_INCREASED_LARGE_INTESTINE_ADENOC
ARCINOMA_INCIDENCE

MP_INCREASED_LEUKEMIA_INCIDENCE
MP_INCREASED_LIVER_ADENOMA_INCIDENC
E

MP_INCREASED_LIVER_TUMOR_INCIDENCE
MP_INCREASED_LUNG_ADENOCARCINOMA_IN
CIDENCE

MP_INCREASED_LUNG_ADENOMA_INCIDENCE
MP_INCREASED_LUNG_CARCINOMA_INCIDEN
CE

MP_INCREASED_LUNG_TUMOR_INCIDENCE
MP_INCREASED_LYMPHOBLASTIC_LYMPHOMA
_INCIDENCE

MP_INCREASED_LYMPHOMA_INCIDENCE
MP_INCREASED_MALIGNANT_TUMOR_INCIDE
NCE

MP_INCREASED_MAMMARY_ADENOCARCINOMA
_INCIDENCE

MP_INCREASED_MAMMARY_GLAND_TUMOR_IN
CIDENCE

MP_INCREASED_MEDULLOBLASTOMA_INCIDE
NCE

MP_INCREASED_MELANOMA_INCIDENCE
MP_INCREASED_METASTATIC_POTENTIAL
MP_INCREASED_MYELOID_SARCOMA_INCIDE
NCE

MP_INCREASED_OSTEOSARCOMA_INCIDENCE
MP_INCREASED_OVARY_TUMOR_INCIDENCE
MP_INCREASED_PANCREAS_TUMOR_INCIDEN
CE

MP_INCREASED_PAPILLOMA_INCIDENCE
MP_INCREASED_PHEOCHROMOCYTOMA_INCID
ENCE

MP_INCREASED_PITUITARY_ADENOMA_INCI
DENCE

MP_INCREASED_PITUITARY_GLAND_TUMOR_
INCIDENCE

MP_INCREASED_PLASMACYTOMA_INCIDENCE
MP_INCREASED_PROSTATE_GLAND_ADENOCA
RCINOMA_INCIDENCE

MP_INCREASED_PROSTATE_INTRAEPITHELI
AL_NEOPLASIA_INCIDENCE

MP_INCREASED_RENAL_CARCINOMA_INCIDE
NCE

MP_INCREASED_RHABDOMYOSARCOMA_INCID
ENCE

MP_INCREASED_SARCOMA_INCIDENCE
MP_INCREASED_SKIN_PAPILLOMA_INCIDEN
CE

MP_INCREASED_SKIN_SQUAMOUS_CELL_CAR
CINOMA_INCIDENCE

MP_INCREASED_SKIN_TUMOR_INCIDENCE
MP_INCREASED_SMALL_INTESTINE_ADENOC
ARCINOMA_INCIDENCE

MP_INCREASED_SQUAMOUS_CELL_CARCINOM
A_INCIDENCE

MP_INCREASED_STOMACH_TUMOR_INCIDENC
E

MP_INCREASED_T_CELL_DERIVED_LYMPHOM
A_INCIDENCE

MP_INCREASED_TESTIS_TUMOR_INCIDENCE
MP_INCREASED_THYROID_ADENOMA_INCIDE
NCE

MP_INCREASED_THYROID_CARCINOMA_INCI
DENCE

MP_INCREASED_THYROID_TUMOR_INCIDENC
E

MP_INCREASED_TRIGEMINAL_NEUROMA_INC
IDENCE

MP_INCREASED_TUMOR_GROWTH_SIZE
MP_INCREASED_TUMOR_INCIDENCE
MP_INCREASED_TUMOR_LATENCY
MP_INCREASED_TUMOR_NECROSIS_FACTOR_
SECRETION

MP_INCREASED_UTERUS_LEIOMYOMA_INCID
ENCE

MP_INCREASED_UTERUS_TUMOR_INCIDENCE
MP_PRENEOPLASIA
MP_TUMOR_REGRESSION